Meeder Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
CIP
CB
Meeder Asset Management's IART Position: Q4 2022 in Review
Meeder Asset Management sold out of Integra LifeSciences (IART) in Q4 2022, closing a stake of 668 shares — an estimated $28K sold.
Meeder Asset Management first reported a position in IART in Q1 2019 and held it in 15 quarters. The position peaked at $108K in Q4 2021. 281 funds tracked by Wall St. Rank hold IART as of Q4 2022.
- Meeder Asset Management reported no remaining Integra LifeSciences position as of Q4 2022 after selling out during the quarter.
- Meeder Asset Management sold 668 Integra LifeSciences shares in Q4 2022, an estimated $28K.
- Meeder Asset Management first reported a position in Integra LifeSciences in Q1 2019 and held it in 15 quarters.
- Meeder Asset Management's Integra LifeSciences position peaked at $108K in Q4 2021.
- 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2022.
Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.